Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics
Abstract Intravitreal injection (IVI) of anti-vascular endothelial growth factor (VEGF) is the standard treatment modality in various types of retinal diseases. However, endophthalmitis remains the most serious complication. Despite the lack of evidence that antibiotics prevent endophthalmitis, topi...
Guardado en:
Autores principales: | Masakazu Morioka, Yoshihiro Takamura, Kazuki Nagai, Shigeo Yoshida, Junya Mori, Masaru Takeuchi, Tomoko Sawada, Kumiko Sone, Hisashi Fukuyama, Sentaro Kusuhara, Tsutomu Yasukawa, Tomoya Murakami, Hitoshi Tabuchi, Daisuke Nagasato, Takao Hirano, Tetsuo Ueda, Tatsuya Jujo, Hirofumi Sasajima, Yoshinori Mitamura, Kunihiro Ishikawa, Masaru Inatani |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9201ac3ac32147808a34465d07612582 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Computational fluid dynamics (CFD) simulation analysis on retinal gas cover rates using computational eye models
por: Makoto Gozawa, et al.
Publicado: (2021) -
Topical bromfenac reduces multiple inflammatory cytokines in the aqueous humour of pseudophakic patients
por: Takehiro Matsumura, et al.
Publicado: (2021) -
Potential bias of preoperative intravitreal anti-VEGF injection for complications of proliferative diabetic retinopathy.
por: Kei Takayama, et al.
Publicado: (2021) -
Endophthalmitis: state of the art
por: Vaziri K, et al.
Publicado: (2015) -
Topical azithromycin or ofloxacin for endophthalmitis
por: Stewart ML, et al.
Publicado: (2012)